Friess Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-130,072
| Closed | -$15.1M | – | 184 |
|
|
2016
Q4 | $15.1M | Buy |
+130,072
| New | +$15.1M | 1.48% | 30 |
|
|
2015
Q3 | – | Sell |
-151,910
| Closed | -$17.6M | – | 197 |
|
|
2015
Q2 | $17.6M | Sell |
151,910
-1,774
| -1% | -$205K | 1.47% | 21 |
|
|
2015
Q1 | $17.7M | Sell |
153,684
-77,100
| -33% | -$8.89M | 1.43% | 27 |
|
|
2014
Q4 | $25.8M | Sell |
230,784
-71,685
| -24% | -$8.02M | 2.08% | 8 |
|
|
2014
Q3 | $28.7M | Sell |
302,469
-21
| -0% | -$1.99K | 2.44% | 6 |
|
|
2014
Q2 | $26M | Sell |
302,490
-53,024
| -15% | -$4.55M | 2.12% | 4 |
|
|
2014
Q1 | $24.8M | Sell |
355,514
-32,960
| -8% | -$2.3M | 1.94% | 17 |
|
|
2013
Q4 | $32.8M | Sell |
388,474
-6,480
| -2% | -$547K | 2.47% | 6 |
|
|
2013
Q3 | $30.4M | Sell |
394,954
-207,960
| -34% | -$16M | 2.43% | 9 |
|
|
2013
Q2 | $35.3M | Buy |
+602,914
| New | +$35.3M | 2.76% | 4 |
|